OpenLegislation

Paragraph 2

Changes not yet applied. Later legislation changes this provision in ways not yet written into the text below:

A statement of the appropriate quantitative particulars of the proprietary medicinal product and, where ingredients other than active ingredients are stated, distinguishing between such ingredients as are and such ingredients as are not active ingredients and, where the quantities stated are those from which the product has been prepared, such quantities being preceded by a statement to that effect, except that where any medicinal product or ingredient is identified by reference to a name, or abbreviation of a name, at the head of a monograph in a specified publication and the quantity of that product or ingredient is stated, the requirements of this paragraph shall be regarded as having been complied with.